Collegium Pharma (COLL) Reports In-Line Q4 EPS; Offers FY23 Revenue Guidance
Go back to Collegium Pharma (COLL) Reports In-Line Q4 EPS; Offers FY23 Revenue Guidance| (NASDAQ: COLL) | Delayed: 22.78 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $22.78 | 52 Week High | $30.58 | |||
| Open | $22.78 | 52 Week Low | $8.24 | |||
| Day High | $22.78 | P/E | N/A | |||
| Day Low | $22.78 | EPS | $0.00 | |||
| Volume | 8,087 | |||||

